Go Pro
→ It’s not about Greenland (From Porter & Company) (Ad)tc pixel Free NVO Stock Alerts

Novo Nordisk A/S (NVO) Short Interest Ratio & Short Volume

Novo Nordisk A/S logo
$47.15 -0.11 (-0.23%)
As of 01:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Novo Nordisk A/S Short Interest Overview

As of July 15, 2026, Novo Nordisk A/S (NVO) had a short interest of 31.09 million shares sold short, representing 0.70% of the public float. This marks a 11.93% increase in short interest since the prior report. The short interest ratio (days to cover) is 3.3, meaning it would take 3.3 days of the average trading volume of 18.14 million shares to cover all short positions.

Current Short Interest
31,094,150 shares
Previous Short Interest
27,780,646 shares
Change Vs. Previous Month
11.93%
Dollar Volume Sold Short
$1.57 billion
Short Interest Ratio
3.3 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
4,465,000,000 shares
Short Percent of Float
0.70%
Today's Trading Volume
5,069,944 shares
Average Trading Volume
18,136,406 shares
Today's Volume Vs. Average
28%
Short Selling Novo Nordisk A/S?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Novo Nordisk A/S and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

NVO Short Interest Over Time

NVO Days to Cover Over Time

NVO Percentage of Float Shorted Over Time

Novo Nordisk A/S Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202631,094,150 shares $1.57 billion +11.9%0.7%3.34 $50.56
6/30/202627,780,646 shares $1.33 billion +13.5%0.6%2.2 $47.92
6/15/202624,478,152 shares $1.07 billion +7.9%0.5%1.7 $43.85
5/29/202622,683,612 shares $1.03 billion +4.4%0.5%1.95 $45.57
5/15/202621,723,616 shares $971.26 million +55.2%0.5%1.21 $44.71
4/30/202613,996,269 shares $591.15 million -17.8%0.3%0.78 $42.24
4/15/202617,019,927 shares $694.45 million -14.6%0.4%1.11 $40.80
3/31/202619,927,815 shares $731.49 million -19.3%0.4%1.1 $36.71
3/13/202624,696,357 shares $938.12 million -12.6%0.6%1.19 $37.99
2/27/202628,261,287 shares $1.06 billion +4.8%0.6%0.85 $37.50
2/13/202626,973,270 shares $1.34 billion -14.9%0.6%0.88 $49.59
1/30/202631,693,294 shares $1.88 billion +12.6%0.7%1.38 $59.40
1/15/202628,156,368 shares $1.61 billion -13.1%0.6%1.29 $57.07
12/31/202532,384,787 shares $1.65 billion +13.7%0.7%1.79 $50.88
12/15/202528,487,274 shares $1.44 billion -3.7%0.6%2.09 $50.38
11/28/202529,593,438 shares $1.46 billion +6.9%0.7%1.22 $49.35
11/14/202527,691,852 shares $1.34 billion -2.0%0.6%1.16 $48.22
10/31/202528,242,397 shares $1.40 billion +5.9%0.6%2.35 $49.40
10/15/202526,670,000 shares $1.51 billion -15.2%0.6%1.5 $56.72
9/30/202531,460,000 shares $1.75 billion +9.5%N/A1.8 $55.52
9/15/202528,740,000 shares $1.60 billion +11.5%N/A1.7 $55.62
8/31/202525,780,000 shares $1.46 billion +22.7%0.6%1.6 $56.51
8/15/202521,020,000 shares $1.10 billion +1.3%N/A1.4 $52.43
7/31/202520,760,000 shares $976.11 million -12.0%0.5%1.5 $47.02
7/15/202523,580,000 shares $1.59 billion -8.3%N/A2.5 $67.32
6/30/202525,700,000 shares $1.77 billion -3.4%0.6%2.5 $69.06
6/15/202526,610,000 shares $2.13 billion -21.0%0.6%2.6 $79.90
5/31/202533,670,000 shares $2.40 billion +22.1%0.8%3.4 $71.40
5/15/202527,580,000 shares $1.82 billion +9.8%0.6%2.9 $66.07
4/30/202525,120,000 shares $1.67 billion +31.7%N/A2.7 $66.53
4/15/202519,070,000 shares $1.23 billion +30.1%0.4%2.1 $64.46
3/31/202514,660,000 shares $1.02 billion +16.0%0.3%1.7 $69.58
3/15/202512,640,000 shares $976.09 million -6.4%0.3%1.4 $77.22
2/28/202513,510,000 shares $1.23 billion -0.2%0.3%1.5 $90.68
2/15/202513,530,000 shares $1.05 billion -0.3%0.3%1.6 $77.94
1/31/202513,570,000 shares $1.14 billion +64.1%N/A1.7 $84.36
1/15/20258,270,000 shares $686.33 million -0.4%N/A1.1 $82.99
12/31/20248,300,000 shares $713.97 million +76.6%N/A1.3 $86.02
12/15/20244,700,000 shares $502.67 million -17.3%N/A0.8 $106.95
11/30/20245,680,000 shares $606.62 million +15.2%N/A1.1 $106.80
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
11/15/20244,930,000 shares $501.58 million -18.5%N/A1 $101.74
10/31/20246,050,000 shares $677.36 million -4.9%N/A1.4 $111.96
10/15/20246,360,000 shares $749.40 million -9.5%N/A1.6 $117.83
9/30/20247,030,000 shares $836.92 million +21.2%N/A1.7 $119.05
9/15/20245,800,000 shares $794.60 million +13.1%N/A1.5 $137.00
8/31/20245,130,000 shares $713.89 million -2.7%N/A1.3 $139.16
8/15/20245,270,000 shares $724.99 million +30.1%N/A1.3 $137.57
7/31/20244,050,000 shares $537.15 million +28.6%N/A1 $132.63
7/15/20243,150,000 shares $445.38 million -30.3%N/A0.8 $141.39
6/30/20244,520,000 shares $645.18 million +3.7%N/A1.2 $142.74
6/15/20244,360,000 shares $621.30 million -2.7%N/A1.2 $142.50
5/31/20244,480,000 shares $606.14 million +20.8%N/A1.1 $135.30
5/15/20243,710,000 shares $499.51 million +1.9%N/A0.8 $134.64
4/30/20243,640,000 shares $466.94 million +12.4%N/A0.8 $128.28
4/15/20243,240,000 shares $401.27 million +14.5%N/A0.6 $123.85
3/31/20242,830,000 shares $363.37 million -31.1%N/A0.6 $128.40
3/15/20244,110,000 shares $543.96 million -15.8%N/A0.8 $132.35
2/29/20244,880,000 shares $584.33 million +4.5%N/A1 $119.74
2/15/20244,670,000 shares $568.43 million -37.9%N/A1 $121.72
1/31/20247,520,000 shares $862.47 million +37.7%N/A1.7 $114.69
1/15/20245,460,000 shares $585.09 million -5.0%N/A1.3 $107.16
12/31/20235,750,000 shares $594.84 million -11.1%N/A1.3 $103.45
12/15/20236,470,000 shares $628.04 million +15.5%N/A1.4 $97.07
11/30/20235,600,000 shares $570.33 million -6.2%N/A1.2 $101.85
11/15/20235,970,000 shares $575.63 million +34.8%N/A1.3 $96.42
10/31/20234,430,000 shares $427.81 million -26.3%N/A1 $96.57
10/15/20236,010,000 shares $613.86 million +1.7%N/A1.3 $102.14
9/30/20235,910,000 shares $537.46 million +5.4%N/A1.5 $90.94
9/15/20235,610,000 shares $267.03 million +187.7%0.3%1.6 $47.60
8/31/20231,950,000 shares $362.15 million -4.9%0.1%1.2 $185.72
8/15/20232,050,000 shares $379.50 million +106.0%0.1%1.4 $185.12
7/31/2023995,300 shares $160.34 million -21.0%0.1%0.7 $161.10
7/15/20231,260,000 shares $201.78 million -44.3%0.1%1 $160.14
6/30/20232,260,000 shares $365.74 million +9.2%0.1%1.6 $161.83
6/15/20232,070,000 shares $336.44 million +16.3%0.1%1.5 $162.53
5/31/20231,780,000 shares $285.69 million +14.1%0.1%1.3 $160.50
5/15/20231,560,000 shares $264.31 million +6.1%0.1%1.1 $169.43
4/30/20231,470,000 shares $245.62 million -14.5%0.1%1.1 $167.09
4/15/20231,720,000 shares $289.99 million -26.2%0.1%1.2 $168.60
3/31/20232,330,000 shares $370.80 million +66.4%0.1%1.7 $159.14
3/15/20231,400,000 shares $197.37 million +28.4%0.1%1 $140.98
2/28/20231,090,000 shares $153.68 million -3.5%0.1%0.8 $140.99
2/15/20231,130,000 shares $159.28 million -33.9%0.1%0.8 $140.96
1/31/20231,710,000 shares $237.31 million +3.6%0.1%1.2 $138.78
1/15/20231,650,000 shares $224.93 million -10.3%0.1%1.2 $136.32
12/30/20221,840,000 shares $249.03 million +34.3%0.1%1.4 $135.34
12/15/20221,370,000 shares $183.14 million -34.1%0.1%1 $133.68
11/30/20222,080,000 shares $259.17 million -20.6%0.1%1.6 $124.60
11/15/20222,620,000 shares $297.74 million -1.1%0.2%1.8 $113.64
10/31/20222,650,000 shares $288.43 million -17.7%0.2%1.7 $108.84
SpaceX is NOT the #1 IPO of 2026 (Ad)

A lesser known AI company is growing faster than both SpaceX and OpenAI. Its coding business reportedly grew from 500 million dollars to 2.5 billion dollars in just five months, and more than 300000 businesses now use its technology. While OpenAI reportedly lost 39 billion dollars last year, this company is projecting a 559 million dollar quarterly profit. Google, Amazon, Nvidia, Microsoft, Sequoia and Peter Thiel's Founders Fund have all reportedly backed it. A publicly traded backdoor may offer regular investors exposure before the expected IPO frenzy, no accredited status or brokerage minimums required.tc pixel

Discover the publicly traded backdoor to this AI company before its IPO
10/15/20223,220,000 shares $334.24 million +0.9%0.2%2 $103.80
9/30/20223,190,000 shares $317.82 million +2.2%0.2%1.9 $99.63
9/15/20223,120,000 shares $322.02 million -9.0%0.2%1.9 $103.21
8/31/20223,430,000 shares $363.92 million +48.5%0.2%2.1 $106.10
8/15/20222,310,000 shares $245.71 million +76.3%0.1%1.5 $106.37
7/31/20221,310,000 shares $152.04 million +26.0%0.1%0.9 $116.06
7/15/20221,040,000 shares $118.80 million -46.4%N/A0.7 $114.23
6/30/20221,940,000 shares $216.17 million -22.7%N/A1.3 $111.43
6/15/20222,510,000 shares $266.89 million +46.8%N/A1.7 $106.33
5/31/20221,710,000 shares $188.78 million -29.1%0.1%1.2 $110.40
5/15/20222,410,000 shares $255.56 million +39.3%0.1%1.6 $106.04
4/30/20221,730,000 shares $197.22 million -47.1%0.1%1.2 $114.00
4/15/20223,270,000 shares $386.51 million +58.0%0.2%2.3 $118.20
3/31/20222,070,000 shares $229.87 million -21.3%0.1%1.4 $111.05
3/15/20222,630,000 shares $269.44 million +10.0%0.2%1.7 $102.45
2/28/20222,390,000 shares $246.05 million -4.8%0.1%1.5 $102.95
2/15/20222,510,000 shares $254.41 million -24.6%0.1%1.7 $101.36
1/31/20223,330,000 shares $332.57 million +0.3%0.2%2.4 $99.87
1/15/20223,320,000 shares $319.78 million +18.2%0.2%2.6 $96.32
12/31/20212,810,000 shares $314.72 million +42.6%0.2%2.5 $112.00
12/15/20211,970,000 shares $229.43 million +3.1%0.1%1.9 $116.46
11/30/20211,910,000 shares $204.05 million -26.0%0.1%2.2 $106.83
11/15/20212,580,000 shares $292.80 million +22.3%0.2%2.8 $113.49
10/29/20212,110,000 shares $232.37 million -17.3%0.1%2.2 $110.13
10/15/20212,550,000 shares $260.97 million +8.1%0.2%2.5 $102.34
9/30/20212,360,000 shares $226.58 million -10.3%0.1%2.3 $96.01
9/15/20212,630,000 shares $266.34 million -24.0%0.2%2.6 $101.27
8/31/20213,460,000 shares $345.90 million +19.7%0.2%3.5 $99.97
8/13/20212,890,000 shares $296.98 million -30.5%0.2%3 $102.76

NVO Short Interest - Frequently Asked Questions

Short interest is the volume of Novo Nordisk A/S shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 31,094,150 shares of NVO short. 0.70% of Novo Nordisk A/S's shares are currently sold short. Learn More on Novo Nordisk A/S's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVO shares currently have a short interest ratio of 3.3. Learn More on Novo Nordisk A/S's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.70% of Novo Nordisk A/S's floating shares are currently sold short.

Novo Nordisk A/S saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 31,094,150 shares, an increase of 11.9% from the previous total of 27,780,646 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.70% of Novo Nordisk A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Novo Nordisk A/S: Johnson & Johnson (1.14%), Merck & Co., Inc. (1.19%), Novartis AG (0.30%), Astrazeneca Plc (0.16%), Pfizer Inc. (2.89%), Bristol Myers Squibb Company (2.20%), GSK PLC Sponsored ADR (0.76%), Sanofi (0.31%), Takeda Pharmaceutical Co. (0.12%), Teva Pharmaceutical Industries Ltd. (2.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling NVO is an investing strategy that aims to generate trading profit from Novo Nordisk A/S as its price is falling. NVO shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Novo Nordisk A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVO, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like NVO:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:NVO) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for P...
The Tomorrow Investor | Sponsoredtc pixel
SpaceX is NOT the #1 IPO of 2026
A lesser known AI company is growing faster than both SpaceX and OpenAI. Its coding business reportedly grew f...
The Oxford Club | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
If your money lives inside one bank, pay close attention. On December 1st, 2025, a Congressional committee pub...
Decentralized Masters | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
This Junior Silver Explorer Is Closing In on Its Biggest Catalyst
A past-producing Nevada silver project holds a historical 36 million ounce silver-equivalent resource, plus mo...
Wall Street Logic | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel